[ad_1]
Moderna Inc mentioned on Saturday the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices voted to advocate the usage of the corporate’s COVID-19 vaccine on individuals 18 years of age and older.
The panel voted 11-Zero in favor of the vaccine, the corporate mentioned in a press launch.
The vote end result got here a day after the Food and Drug Administration’s authorization for emergency use of Moderna’s COVID-19 vaccine.
“ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine,” Chief Executive Officer Stephane Bancel mentioned within the launch.
Moderna’s is the second COVID-19 vaccine to obtain approval within the United States after an analogous vaccine from Pfizer Inc and German associate BioNTech SE bought the inexperienced mild for emergency use.
US distribution of Moderna’s vaccine started on Saturday, with greater than 3,700 websites on account of begin receiving and administering pictures as quickly as Monday.
(Except for the headline, this story has not been edited by NDTV workers and is printed from a syndicated feed.)
[ad_2]
Source hyperlink